Roorkee

Pharma Courses
  • PharmaTutor
    8 March 2016

    Work as Quality Assurance Executive in Pharma Client of Nextus Solutions

    Nextus is a dynamic organization offering Strategic Management & HR Consulting Solutions. We offer a range of services covering Business Consultancy, Communication Planning, Recruitment & Training. With a focused Pharmaceutical & Healthcare Industry Practice, Nextus is one of fastest growing Strategic Business Consultancy companies in India, with comprehensive Recruitment & Training solutions. We bring deep, functional expertise to focus on client’s critical issues and opportunities. Our systematic and result-oriented approach helps our clients achieve their goals in cost-effective and timely manner.

  • 18 December 2015
    Looking for Product Executive/Product Manager (PMT) in AXA Parenterals

    AXA Parenterals Ltd. is into manufacturing & marketing of Sterile Parenterals preparations, life saving medicines and hospital products. AXA Parenterals Ltd. has first of its kind I.V. Fluid plant in Roorkee, Uttarakhand, the hilly state of India. AXA's Intravenous Fluids are manufactured in High Quality Medigrade Plastic LDPE granules under aseptic conditions using the latest “State-Of-The-Art” AFFS Technology. AXA products are marketed across India through its own Sales, Marketing and Distribution network.

  • 23 August 2015
    Opportunity for Pharmacist in Indian Institute of Technology Roorkee

    Indian Institute of Technology Roorkee, Roorkee invites the on-line applications for the following posts as per details given against each.

    Post: Pharmacist

  • 7 July 2015
    Walk in interview for Junior Research Fellow in IITR

    Applications are invited from Indian nationals only for project position(s) as per the details given below for the consultancy/researchp roject(s) under the Principal investigator (Name: Dr. P. Jeeyanandam), Dept./Centre Chemistry..... Indian Institute of Technology, Roorkee.

    Post: Junior Research Fellow

  • 3 March 2014
    Walk in for M.Pharm for post of junior research fellow in Indian Institute of Technology

    Indian Institute of Technology - Roorkee is among the foremost of institutes of national importance in higher technological education and in engineering, basic and applied research. Since its establishment, the Institute has played a vital role in providing the technical manpower and know-how to the country and in pursuit of research. The Institute ranks amongst the best technological institutions in the world and has contributed to all sectors of technological development.

  • 24 December 2013
    WALK IN for Junior Research Fellow @ Indian Institute of Technology

    Indian Institute of Technology – Roorkee is among the foremost of institutes of national importance in higher technological education and in engineering, basic and applied research. Since its establishment, the Institute has played a vital role in providing the technical manpower and know-how to the country and in pursuit of research. The Institute ranks amongst the best technological institutions in the world and has contributed to all sectors of technological development. It has also been considered a trend-setter in the area of education and research in the field of science, technology, and engineering.

    Applications are invited from Indian nationals only for project position(s) as per the details given below for the research project(s) under the Principal investigator (Name: Dr. Pravindra Kumar), Dept./Centre DEPARTMENT OF BIOTECHNOLOGY, Indian Institute of Technology, Roorkee.

    Post: Junior Research Fellow- 1 Nos.

  • 4 October 2013
    Working opportunity in Indian Institute of Technology as JRF/SRF/RA – B.Pharm/M.Pharm can apply

    Indian Institute of Technology – Roorkee is among the foremost of institutes of national importance in higher technological education and in engineering, basic and applied research.

  • 24 March 2013
    Vacancy for Medical Representative by TrueOsis Consultancy

    TrueOsis ever since its inception in 2007 has been involved in providing high quality manpower solutions and services. We have been successful in providing consistent and reliable services to our customers who include BFSI, BPOs, IT Industries, Pharma, Private Manufacturing Enterprises and FMCG Companies.
    The culture at TrueOsis is based on strong interaction with customers in order to provide complete satisfaction in terms of desired output.

  • 14 February 2013
    NOVEL DRUG DELIVERY SYSTEM

    About Authors:
    Aruna Rastogi
    Roorkee College of Pharmacy and UTU
    Patanjali Ayurved Ltd, Sr. Chemist
    arunarastogi10@gmail.com

    1.   INTRODUCTION
    1.1 NOVEL DRUG DELIVERY SYSTEM:
    The method by which a drug is delivered can have a significant effect on its efficacy. Some drugs have an optimum concentration range within which maximum benefit is derived, and concentrations above or below this range can be toxic or produce no therapeutic benefit at all. On the other hand, the very slow progress in the efficacy of the treatment of severe diseases, has suggested a growing need for a multidisciplinary approach to the delivery of therapeutics to targets in tissues. From this, new ideas on controlling the pharmacokinetics, pharmacodynamics, non-specific toxicity, immunogenicity, biorecognition, and efficacy of drugs were generated. These new strategies, often called drug delivery systems (DDS), are based on interdisciplinary approaches that combine polymer science, pharmaceutics, bioconjugate chemistry, and molecular biology.

  • 2 January 2013
    A NOVEL ANTIDIABETIC DRUG: MIGLITOL: A REVIEW

    About Authors:
    Rahul kumar Singh
    M.Pharm (Quality Assurance)
    Sr. Officer Quality Assurance at Shreya Life Sciences Pvt. Ltd.,
    Roorkee, Uttarakhand
    rahulsingh.qa@gmail.com

    Abstract
    Miglitol, an oral alpha-glucosidase inhibitor, is a desoxynojirimycin derivative that delays the digestion of ingested carbohydrates, thereby resulting in a smaller rise in blood glucose concentration following meals. As a consequence of plasma glucose reduction, miglitol reduce levels of glycosylated hemoglobin in patients with Type II (non-insulin-dependent) diabetes mellitus. Systemic nonenzymatic protein glycosylation, as reflected by levels of glycosylated hemoglobin, is a function of average blood glucose concentration over time. Because its mechanism of action is different, the effect of miglitol to enhance glycemic control is additive to that of sulfonylureas when used in combination. In addition, miglitol diminishes the insulinotropic and weight-increasing effects of sulfonylureas. Miglitol has minor inhibitory activity against lactase and consequently, at the recommended doses, would not be expected to induce lactose intolerance.

Subscribe to Roorkee